Australia’s Neuren Pharma shares plunged to their lowest level in more than two months after the company dramatically cut its royalty forecast, sparking investor concerns over potential profit declines. Market watchers remain on edge as the stock faces renewed selling pressure
Australia’s Commonwealth Bank (CBA) has smashed records with a stellar annual profit, driven by soaring home loan growth and sharp cost control. However, despite this remarkable success, investors have been selling off pricey shares, revealing a cautious sentiment in the market
Australia’s Viva Energy shares plunged 11% after an unexpected slump in convenience store sales. This sharp decline has raised concerns about the company’s near-term profitability amid shifting consumer behaviors, Reuters reports
